Population differences between COVID-19 and other postviral olfactory dysfunction: Results from a large case-control study

Int Forum Allergy Rhinol. 2022 Aug;12(8):1063-1066. doi: 10.1002/alr.22955. Epub 2022 Jan 19.

Authors

Nikita Chapurin^{1

2}, Spencer Dennis¹, Naweed I Chowdhury^{1

2}, Timothy Trone^{1

2}, Basil Chaballout³, Elizabeth Longino¹, Justin H Turner^{1

2}, Rakesh K Chandra^{1

2}

Affiliations

¹ Division of Rhinology/Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
² Vanderbilt University Medical Center Smell and Taste Center, Nashville, USA.
³ University of South Carolina School of Medicine, Greenville, South Carolina, USA.

No abstract available

Keywords: SARS-CoV-2 (COVID-19); TDI testing; olfaction; olfactory disorders; postviral olfactory dysfunction.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

COVID-19* / epidemiology
Case-Control Studies
Humans
Olfaction Disorders* / epidemiology
Smell

Grants and funding